Attached files

file filename
EX-10.1 - INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN, AS AMENDED AND RESTATED - INTUITIVE SURGICAL INCdex101.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report: April 21, 2011

(Date of earliest event reported)

 

 

INTUITIVE SURGICAL, INC.

(exact name of registrant as specified in its charter)

 

 

 

Delaware   000-30713   77-0416458

(State or other jurisdiction

of incorporation)

 

Commission

File Number

 

(I.R.S. Employer

Identification No.)

1266 Kifer Road

Sunnyvale, California 94086

(Address of Principal executive offices, including zip code)

(408) 523-2100

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Compensatory Arrangements of Certain Officers.

Approval of the Amendment and Restatement of the 2010 Incentive Award Plan

The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, an increase in the number of shares of common stock authorized for issuance pursuant to awards granted under the Company’s 2010 Incentive Award Plan (the “2010 Plan”) from 1,250,000 to 2,450,000 (the “Award Pool Increase”). According to the final results from the Company’s Annual Meeting of Stockholders held on April 21, 2011 (the “Annual Meeting”), the Company’s stockholders approved the amended and restatement of the 2010 Plan to provide for the Award Pool Increase. The foregoing description of the 2010 Plan, as amended and restated, is qualified in its entirety by reference to the text of the amended and restated 2010 Plan, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

At the Annual Meeting, the stockholders of the Company voted on the following five proposals, each of which are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 1, 2011 (the “Proxy”):

Proposal No. 1: To elect three directors to the Board of Directors to serve a three-year term expiring at the 2014 Annual Meeting of Stockholders:

 

Nominee

 

For

 

Against

 

Abstain

 

Broker Non-votes

Floyd D. Loop, M.D.   29,276,336   436,169   42,612   4,795,243
George J. Stalk, Jr.   29,334,061   378,184   42,872   4,795,243
Craig H. Barratt, Ph.D.   29,341,789   369,141   44,187   4,795,243

Each of the nominees recommended in Proposal No. 1 was elected.

Proposal No. 2: To approve an amendment and restatement of the Company’s 2010 Incentive Award Plan to increase the number of shares of common stock reserved for issuance by 1,200,000 from 1,250,000 to 2,450,000:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

20,989,274   8,729,615   36,228   4,795,243

Proposal No. 2 was approved.

Proposal No. 3: To approve, by non-binding vote, the compensation of the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis, compensation tables and narrative discussion in the Proxy:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

25,579,080   4,139,468   36,569   4,795,243

Proposal No. 3 was approved.

Proposal No. 4: To recommend, by non-binding vote, the frequency of the advisory vote on the compensation of the Company’s named executive officers:

 

1 Year

 

2 Years

 

3 Years

 

Abstain

 

Broker Non-Votes

15,636,344   156,562   13,936,329   25,882   4,795,243


The stockholders recommended an advisory vote to occur every year.

Proposal No. 5: To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011:

 

For

 

Against

 

Abstain

34,168,272   356,018   26,070

Proposal No. 5 was approved.

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits.

 

Exhibit

Number

 

Description

10.1   Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    INTUITIVE SURGICAL, INC.
Date: April 26, 2011     By  

/s/ Marshall L. Mohr

                  Name: Marshall L. Mohr
     

            Title: Senior Vice President and

                       Chief Financial Officer